Dr. Durkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Campus Box 8051
4523 Clayton Ave
Saint Louis, MO 63110Phone+1 314-362-9098Fax+1 314-362-9851
Summary
- Dr. Michael Durkin is an infectious disease specialist in Saint Louis, MO and is affiliated with Barnes-Jewish Hospital and Washington University School of Medicine. He received his medical degree from Medical College of Wisconsin and has been in practice 9 years. He specializes in healthcare associated infections and is experienced in general infectious disease, public health, epidemiology, infection control, and antibiotic stewardship.
Education & Training
University of North CarolinaMPH, Epidemiology, 2013 - 2015
Duke University HospitalFellowship, Infectious Disease, 2012 - 2015
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2008 - 2011
Medical College of WisconsinClass of 2008
Certifications & Licensure
MO State Medical License 2011 - 2026
NC State Medical License 2012 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Fellow Society for Healthcare Epidemiology of America, 2022
- Fellow Infectious Diseases Society of America, 2021
Clinical Trials
- CTTI Risk Factors for HABP/VABP Study Start of enrollment: 2016 Feb 01
- Nutraceutical Efficacy for rUTI Start of enrollment: 2018 Mar 22
- Stigma and a Shared Decision Aid Start of enrollment: 2022 Apr 07
- Join now to see all
Publications & Presentations
PubMed
- Eliciting Clinician Perspectives on Asymptomatic Bacteriuria to Identify Targets for Antimicrobial Stewardship Education and Decision Support.Michael J Durkin, Viktoria Schmitz, Kevin Hsueh, Katheryn Ney, Mary C Politi
Open Forum Infectious Diseases. 2024-08-01 - Evaluation of patients labeled with a penicillin allergy to promote antimicrobial stewardship in dental practice.Peter B Lockhart, Michael J Durkin, Kimberly G Blumenthal, Thomas M Paumier, Larry M Baddour
Journal of the American Dental Association. 2024-07-01 - Utilization of broad- versus narrow-spectrum antibiotics for the treatment of outpatient community-acquired pneumonia among adults in the United States.Katelin B Nickel, Michael J Durkin, Margaret A Olsen, John M Sahrmann, Elizabeth Neuner
Pharmacoepidemiology and Drug Safety. 2024-04-01
Journal Articles
- Addiction Medicine Consultations Reduce Readmission Rates for Patients with Serious Infections from Opioid Use DisorderDavid K Warren, Michael J Durkin, Evan S Schwarz, Clinical Infectious Diseases
Books/Book Chapters
Press Mentions
IDSA Honors 199 Distinguished Clinicians, Scientists with FIDSA DesignationNovember 16th, 2021
Halting Opioid Abuse Aim of Several Grants from NIH, CDCDecember 3rd, 2019
Grant Support
- Developmental Center for AIDS Research Grant - Scientific Working GroupNIH(NIAID) - Co-I on D-CFAR and Co-PI of Scientific Working Group2024–2029
- Informatics Approaches to Understand and Reduce Inappropriate Antibiotic Prescribing by DentistsNIH(NIDCR)2023–2028
- Comparative Risk of Oral Complications Associated with Medications for Opioid Use Disorder: A Mixed-Methods ApproachNIH (NIDCR)2023–2028
- Identifying Optimal Antibiotic Regimens to Treat Urinary Tract Infections During PregnancyNIH(NICHD)2022–2027
- Washington University & BJC Epicenter to Prevent Healthcare Associated Infections & Antibiotic ResistanceCDC2021–2026
- Using Implementation Science and Informatics to Develop and Pilot Test Antibiotic Stewardship Clinical Decision SupportNIH(NIDCR)2021–2026
- Impact of removing low yield penicillin allergy alerts on surgical site infection ratesAHRQ2024–2025
- Dental Safety of Transmucosal Buprenorphine Among Individuals Receiving OpioidsNIH(NIDA)2023–2025
- Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter NetworkCDC(NCEZID)2020–2025
- Stakeholders' Perceptions of Consensus Guidelines about Antibiotics for Asymptomatic BacteriuriaWashington University Institute for Clinical and Translational Sciences2023–2024
- Moving Upstream – Expanding Harm Reduction Training and Low‐Barrier Care for Unstably Housed People Who Inject DrugsWashington University Institute for Public Health2023–2024
- Piloting a Shared Decision-Making Aid for Reducing Stigma in Drug Use and HIV Harm Reduction in a Rural SettingNIDA2021–2023
- Evaluation of Aerosol Composition in Dental SettingsNIH(NIDCR)2021–2022
- Dissemination and Implementation of a HCV telehealth program for persons who inject drugsWashington University ICTS2021–2022
- Determining the acceptability and feasibility of mobile-health approaches to gather clinical information from patients at home following hospital dischargeNCATS2020–2022
- Loan Repayment ProgramNIH (NIAID and NIDCR)2017–2022
- Research on the cost of inappropriate antibiotic prescribing in outpatient healthcare settingsPew Charitable Trusts2020–2021
- Assessment of Personal Protective Equipment for Dental Healthcare ProfessionalsNIH (NIDCR)2020–2021
- Evaluation of Aerosol Generating Procedures in Dental SettingsNIH (NIDCR)2020–2021
- Increasing use of MAT to address opioid use among patients with bacterial and fungal infections related to injection drug use - RuralCDC SHEPheRD2019–2021
- Increasing use of MAT to address opioid use among patients with bacterial and fungal infections related to injection drug use - UrbanCDC SHEPheRD Contract2019–2021
- Washington University & BJC Epicenter for Prevention of Healthcare Associated InfectionsCDC2016–2021
- Antimicrobial Stewardship ActivitiesCDC2018–2020
- KL2Washington University ICTS/NIH (NCATS)2016–2019
Professional Memberships
- Member
- Society for Healthcare Epidemiology of AmericaMember
- International Association for Dental ResearchMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
